Ollin Biosciences Enters Definitive Agreement to Be Bought by Johnson & Johnson
Innovent Biologics says Ollin Biosciences has entered a definitive agreement to be acquired by Johnson & Johnson.
Innovent Biologics says Ollin Biosciences has entered a definitive agreement to be acquired by Johnson & Johnson.